Dr. Grosskreutz is a member of the Glaucoma Service who specializes in the medical management of glaucoma.
After receiving a B.S. in Physics from Washington University and an M.S. in Physics from the University of Iowa, she went on to earn her M.D. and Ph.D. from the University of Iowa College of Medicine. She completed her ophthalmology residency at Harvard Medical School, followed by a glaucoma fellowship at Mass. Eye and Ear.
Dr. Grosskreutz’s research focuses on preclinical drug development for eye disease.
For a full publication list, please see her CV.
Halpren DL, Grosskreutz CL. Glaucomatous optic neuropathy: mechanisms of disease. Ophthalmol Clin North Am. 2002; 15(1):61-8.
Adelman RA, Brauner SC, Afshari NA, Grosskreutz CL. Cataract formation after initial trabeculectomy in young patients. Ophthalmology. 2003; 110(3):625-9.
Zacks DN, Hanninen V, Pantcheva M, Ezra E, Grosskreutz C, Miller JW. Caspase activation in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci. 2003; 44(3):1262-7.
Fine LC, Chen TC, Grosskreutz CL, Pasquale LR. Management and prevention of thin, cystic blebs. Int Ophthalmol Clin. 2004;44(1):29-42
Huang W, Dobberfuhl A, Filippopoulos T, Ingelsson, Fileta JB, Poulin NR, Grosskreutz CL. Transcriptional up-regulation and activation of initiating caspases in experimental glaucoma. Amer J Path. 2005;167(3):673-681.
View a complete list of publications on pubmed.gov>>